Jun 30
In June, the Food and Drug Administration approved the drug Xocova (ensitrelvir) as the very first post-exposure prophylaxis for Sars-CoV-2,
Saved in our archive
seen from China
seen from United States
seen from United States
seen from United States
seen from United States
seen from United Kingdom
seen from United States
seen from Malaysia
seen from China
seen from Maldives
seen from Netherlands
seen from United States
seen from Brazil
seen from United States
seen from United States
seen from Finland
seen from Malaysia
seen from Yemen
seen from Singapore
seen from Türkiye
In June, the Food and Drug Administration approved the drug Xocova (ensitrelvir) as the very first post-exposure prophylaxis for Sars-CoV-2,
Saved in our archive
SciTech Chronicles. . . . . . . . .May 15th, 2026
Vol VI Issue 39 Who Said this? A little nonsense now and then is relished by the wisest men. Today, 466 links Curated Today's Five Links Sci
ENSITRELVIR
Ensitrelvir S-217622, S 217622, Xocova, SHIONOGI, 6-[(6-chloro-2-methylindazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazine-2,4-dione CAS 2647530-73-0 C22H17ClF3N9O2531.9SynonymsBDBM513874bioRxiv20220126.477782, S-217622 Ensitrelvir fumarateCAS No. : 2757470-18-9 C22 H17 Cl F3 N9 O2 . C4 H4 O4 1,3,5-Triazine-2,4(1H,3H)-dione,…
View On WordPress